
Experience relief from chest discomfort and improved energy levels.
Only charged if approved
90-day supply + shipping
With RTHM discount
Paid every 90 days
(only charged if approved)
90-day supply + shipping, paid to the pharmacy
With RTHM discount
Ivabradine specifically targets the sinoatrial node, slowing down a racing heart rate, and alleviating the pounding sensations associated with POTS and other forms of dysautonomia.
By slowing the heart rate, ivabradine enhances blood flow and oxygen delivery to the heart muscle, enabling improved physical activity and reducing post-exertional malaise.
Ivabradine's action reduces metabolic strain on the heart, leading to increased energy, better heart filling, and lower lactate levels for improved endurance and vitality.
Ivabradine is particularly effective for:
Patients with Long COVID, ME/CFS, or POTS experiencing these symptoms may benefit from ivabradine.
Ivabradine is generally safe and well-tolerated. Patients with conditions such as atrial fibrillation, bradycardia, or liver disease should consult their healthcare provider before use.
Ivabradine may not be suitable for individuals with:
A study with 22 patients showed ivabradine lowered heart rate with no significant side effects in patients with hyperadrenergic POTS.
"Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome"
A retrospective study of 49 patients showed ivabradine significantly improved lightheadedness and palpitations in POTS patients. 78% of the cohort reported improvement.
"Ivabradine in the treatment of postural tachycardia syndrome (POTS), a single center experience"
A retrospective study of 22 patients showed ivabradine significantly improved symptoms of POTS. 70% of patients also reported improved fatigue.
"Single centre experience of ivabradine in postural orthostatic tachycardia syndrome"
A study with 22 patients showed ivabradine lowered heart rate with no significant side effects in patients with hyperadrenergic POTS.
"Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome"
View StudyA retrospective study of 49 patients showed ivabradine significantly improved lightheadedness and palpitations in POTS patients. 78% of the cohort reported improvement.
"Ivabradine in the treatment of postural tachycardia syndrome (POTS), a single center experience"
View StudyA retrospective study of 22 patients showed ivabradine significantly improved symptoms of POTS. 70% of patients also reported improved fatigue.
"Single centre experience of ivabradine in postural orthostatic tachycardia syndrome"
View Study"Wow, this drug gave me my life back. Having POTS syndrome (with no cure) left me almost bedridden. Every time I would stand up, my heart rate would go through the roof. I have been on this drug for 5 years now, and I'm finally stable!!!"
"2 x 5mg per day for autonomic nervous system problem POTs, caused by Covid. Ivabradine so far is a game-changer in terms of lowering my heart rate and reducing the awful adrenaline rushes and associated pain and bladder issues. I have gone from being so debilitated and unable to stand for long or do..."
"Ivabradine changed my life. I have POTS due to long COVID, and tachycardia but no blood pressure alterations (that's why my cardio chose this treatment instead of beta blockers). My resting HR was 120, now it's 80, it's really incredible to see what it has done to me."
"80% of patients report at least some improvement on ivabradine for POTS"